ANA-12
ANA-12 is a selective TrkB antagonist that is used in scientific research. It is a small molecule that has been shown to inhibit the activity of the TrkB receptor, which is involved in the regulation of neuronal survival and differentiation. ANA-12 has been used in various studies to investigate the role of TrkB in different biological processes and diseases, including neurodegenerative diseases and cancer.
Mechanism of Action[edit | edit source]
ANA-12 works by selectively binding to the TrkB receptor, thereby inhibiting its activity. The TrkB receptor is a type of tyrosine kinase receptor that is activated by brain-derived neurotrophic factor (BDNF). By blocking the activity of TrkB, ANA-12 can prevent the survival and differentiation signals that are normally sent by BDNF.
Uses in Research[edit | edit source]
ANA-12 has been used in a variety of research studies to investigate the role of TrkB in different biological processes and diseases. For example, it has been used to study the role of TrkB in neuronal survival and differentiation, as well as in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. In addition, ANA-12 has been used to investigate the role of TrkB in cancer, as this receptor has been found to be overexpressed in certain types of cancer.
Potential Therapeutic Applications[edit | edit source]
While ANA-12 is primarily used in research, it has potential therapeutic applications. For example, it could potentially be used as a treatment for diseases in which TrkB is overactive, such as certain types of cancer. In addition, it could potentially be used to treat neurodegenerative diseases by inhibiting the activity of TrkB and thereby reducing neuronal death.
Safety and Side Effects[edit | edit source]
As a research chemical, ANA-12 is not approved for use in humans and its safety and side effects have not been fully studied. However, in animal studies, it has been shown to be well-tolerated with no significant side effects reported.
See Also[edit | edit source]
| ANA-12 Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
